MeSH term
Frequency | Condition_Probility | Acute Disease | 3 | 0.0 |
Adult | 11 | 0.0 |
Comparative Study | 12 | 0.0 |
Humans | 94 | 0.0 |
Research Support, Non-U.S. Gov't | 75 | 0.0 |
*Transcription, Genetic | 2 | 0.0 |
Cell Differentiation/drug effects | 3 | 0.0 |
Cells, Cultured | 12 | 0.0 |
DNA-Binding Proteins/genetics/*physiology | 4 | 1.0 |
Female | 20 | 0.0 |
Transcription, Genetic | 7 | 0.0 |
Animals | 53 | 0.0 |
Casein Kinase II | 3 | 2.0 |
Cell Line | 13 | 0.0 |
Mice | 33 | 0.0 |
Molecular Sequence Data | 17 | 0.0 |
Phosphorylation | 7 | 0.0 |
Protein Binding | 9 | 0.0 |
Recombinant Fusion Proteins/genetics/metabolism | 2 | 0.0 |
Repressor Proteins/genetics/*metabolism | 2 | 1.0 |
Transcription Factors/genetics/*metabolism | 10 | 1.0 |
Two-Hybrid System Techniques | 4 | 0.0 |
B-Lymphocytes/*physiology | 2 | 1.0 |
Cell Differentiation | 14 | 0.0 |
DNA/metabolism | 5 | 0.0 |
DNA-Binding Proteins/*physiology | 4 | 0.0 |
Mice, Inbred C57BL | 2 | 0.0 |
*Repressor Proteins | 51 | 4.0 |
Transcription Factors/metabolism/*physiology | 2 | 2.0 |
DNA-Binding Proteins/*metabolism | 8 | 0.0 |
Immunohistochemistry | 10 | 0.0 |
Transcription Factors/*metabolism | 10 | 0.0 |
Base Sequence | 17 | 0.0 |
Cell Differentiation/*drug effects | 2 | 1.0 |
DNA-Binding Proteins/metabolism | 5 | 0.0 |
Enzyme Activation | 2 | 0.0 |
Neuroblastoma/*pathology | 2 | 3.0 |
*Protein-Serine-Threonine Kinases | 2 | 0.0 |
Transcription Factors/metabolism | 2 | 0.0 |
Tretinoin/*pharmacology | 2 | 0.0 |
Tumor Cells, Cultured | 21 | 0.0 |
Blotting, Western | 4 | 0.0 |
*Cell Differentiation | 3 | 1.0 |
Dimerization | 4 | 0.0 |
*Neoplasm Proteins | 19 | 2.0 |
Research Support, U.S. Gov't, P.H.S. | 41 | 0.0 |
Transfection | 16 | 0.0 |
Culture Media | 4 | 0.0 |
Sensitivity and Specificity | 2 | 0.0 |
Predictive Value of Tests | 2 | 0.0 |
Alternative Splicing | 2 | 0.0 |
Blotting, Northern | 7 | 0.0 |
Cell Division | 8 | 0.0 |
Cloning, Molecular | 3 | 0.0 |
DNA, Complementary/metabolism | 3 | 0.0 |
Models, Biological | 2 | 0.0 |
RNA/metabolism | 2 | 0.0 |
Rats | 16 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 4 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 9 | 0.0 |
Tissue Distribution | 3 | 0.0 |
Helix-Loop-Helix Motifs | 6 | 2.0 |
*Nerve Tissue Proteins | 3 | 0.0 |
Signal Transduction | 3 | 0.0 |
3T3 Cells | 6 | 0.0 |
Cell Division/physiology | 3 | 0.0 |
Gene Expression Regulation, Developmental | 4 | 0.0 |
Infant | 5 | 0.0 |
*Transcription Factors | 15 | 0.0 |
Analysis of Variance | 2 | 0.0 |
*Helix-Loop-Helix Motifs | 16 | 17.0 |
In Situ Hybridization | 5 | 0.0 |
Male | 23 | 0.0 |
RNA, Messenger/metabolism | 9 | 0.0 |
DNA-Binding Proteins/genetics/*metabolism | 6 | 0.0 |
Promoter Regions (Genetics) | 9 | 0.0 |
Astrocytes/metabolism | 3 | 4.0 |
DNA-Binding Proteins/*genetics | 7 | 0.0 |
Gene Expression Regulation/physiology | 2 | 0.0 |
Helix-Loop-Helix Motifs/genetics | 4 | 10.0 |
Oligodendroglia/metabolism | 2 | 4.0 |
Phenotype | 2 | 0.0 |
Transcription Factors/*genetics | 8 | 0.0 |
Great Britain | 2 | 0.0 |
Middle Aged | 9 | 0.0 |
Gene Expression/drug effects | 2 | 0.0 |
*Gene Expression Regulation | 5 | 0.0 |
Genes, Dominant | 2 | 0.0 |
Mutagenesis, Site-Directed | 2 | 0.0 |
Mutation | 5 | 0.0 |
Trans-Activation (Genetics) | 2 | 0.0 |
Up-Regulation | 10 | 0.0 |
DNA-Binding Proteins/genetics | 3 | 0.0 |
Helix-Loop-Helix Motifs/*physiology | 3 | 23.0 |
RNA, Messenger/*metabolism | 2 | 0.0 |
Adolescent | 6 | 0.0 |
Case-Control Studies | 2 | 0.0 |
Risk Factors | 2 | 0.0 |
RNA, Messenger/genetics/metabolism | 3 | 0.0 |
Dexamethasone/*pharmacology | 2 | 0.0 |
Transcription Factors/genetics | 3 | 0.0 |
DNA-Binding Proteins/*genetics/physiology | 2 | 2.0 |
Gene Expression Regulation/*drug effects | 3 | 0.0 |
Transcription Factors/*genetics/physiology | 2 | 2.0 |
Gene Expression | 7 | 0.0 |
Mice, Knockout | 4 | 0.0 |
Polymerase Chain Reaction | 5 | 0.0 |
RNA, Messenger/analysis | 4 | 0.0 |
Time Factors | 5 | 0.0 |
*Chromogenic Compounds | 2 | 33.0 |
*Apoptosis | 2 | 0.0 |
Heat-Shock Proteins 90/genetics | 2 | 33.0 |
Histone Deacetylases/*antagonists & inhibitors | 2 | 4.0 |
Protein Kinase C/metabolism | 2 | 0.0 |
Protein-Serine-Threonine Kinases/metabolism | 2 | 0.0 |
Cell Lineage | 2 | 0.0 |
Flow Cytometry | 2 | 0.0 |
Microscopy, Fluorescence | 2 | 0.0 |
Neurons/metabolism | 2 | 0.0 |
Precipitin Tests | 2 | 0.0 |
RNA Interference | 2 | 0.0 |
Aged | 5 | 0.0 |
Incidence | 2 | 0.0 |
Cell Line, Tumor | 5 | 0.0 |
Embryo/metabolism | 2 | 1.0 |
Gene Expression Regulation | 8 | 0.0 |
Retinoblastoma/genetics/*metabolism | 2 | 50.0 |
Amino Acid Sequence | 9 | 0.0 |
Transcription Factors/genetics/*physiology | 3 | 1.0 |
DNA Primers | 4 | 0.0 |
DNA-Binding Proteins/chemistry/*metabolism | 2 | 1.0 |
Down-Regulation | 4 | 0.0 |
Binding Sites/genetics | 3 | 0.0 |
PC12 Cells | 2 | 0.0 |
Promoter Regions (Genetics)/physiology | 2 | 1.0 |
Repressor Proteins/*genetics | 2 | 0.0 |
Transcription Factors/*genetics/*metabolism | 3 | 2.0 |
Immunoenzyme Techniques | 3 | 0.0 |
Luciferases/metabolism | 2 | 0.0 |
Promoter Regions (Genetics)/*genetics | 2 | 0.0 |
Repressor Proteins/*metabolism | 2 | 1.0 |
Saccharomyces cerevisiae | 2 | 0.0 |
DNA, Complementary | 3 | 0.0 |
Hydroxamic Acids/*pharmacology | 2 | 4.0 |
Gene Expression Regulation, Developmental/genetics | 2 | 2.0 |
Helix-Loop-Helix Motifs/*genetics | 5 | 13.0 |
Phylogeny | 2 | 0.0 |
Sequence Homology, Amino Acid | 5 | 0.0 |
Evaluation Studies | 2 | 0.0 |
Urine/*microbiology | 2 | 40.0 |
Cell Differentiation/genetics | 2 | 0.0 |
Cyclic AMP/pharmacology | 2 | 1.0 |
Genes, Reporter | 2 | 0.0 |
*Promoter Regions (Genetics) | 2 | 0.0 |
Dose-Response Relationship, Drug | 3 | 0.0 |
Electrophoresis, Polyacrylamide Gel | 2 | 0.0 |
Transforming Growth Factor beta/physiology | 2 | 2.0 |
Transcription Factors/*genetics/metabolism | 2 | 0.0 |
Cell Differentiation/physiology | 2 | 0.0 |
Chick Embryo | 2 | 0.0 |
Repressor Proteins/*physiology | 2 | 1.0 |
*Dental Devices, Home Care | 3 | 75.0 |
Single-Blind Method | 2 | 0.0 |
DNA, Complementary/genetics | 2 | 0.0 |
Transforming Growth Factor beta/*pharmacology | 2 | 0.0 |
*CDC2-CDC28 Kinases | 2 | 0.0 |
Cell Cycle/*physiology | 3 | 1.0 |
Cyclin-Dependent Kinases/*metabolism | 2 | 0.0 |
Helix-Loop-Helix Motifs/genetics/physiology | 2 | 40.0 |
Protein-Serine-Threonine Kinases/*metabolism | 2 | 0.0 |
*Proto-Oncogene Proteins | 4 | 0.0 |
Stem Cell Factor/*pharmacology | 2 | 3.0 |
Binding Sites | 4 | 0.0 |
Cell Cycle | 3 | 0.0 |
Cyclins/metabolism | 2 | 0.0 |
U937 Cells | 2 | 0.0 |
DNA-Binding Proteins/*biosynthesis/genetics | 3 | 3.0 |
*DNA-Binding Proteins | 2 | 0.0 |
Dental Plaque/*prevention & control | 2 | 66.0 |
B-Lymphocytes/metabolism | 2 | 1.0 |
Chromosome Mapping | 2 | 0.0 |
In Situ Hybridization, Fluorescence | 2 | 0.0 |
DNA-Binding Proteins/*genetics/*metabolism | 3 | 2.0 |
Nerve Tissue Proteins/genetics/*metabolism | 2 | 1.0 |
Consensus Sequence | 2 | 0.0 |
Child | 3 | 0.0 |
Child, Preschool | 3 | 0.0 |
Macromolecular Substances | 2 | 0.0 |
Conserved Sequence | 2 | 0.0 |
*Gene Expression Regulation, Neoplastic | 2 | 0.0 |
Microscopy, Electron | 2 | 0.0 |
Oligonucleotide Array Sequence Analysis | 5 | 0.0 |
Genes, myc | 2 | 0.0 |
Transcription Factors/*physiology | 2 | 0.0 |
Cell Division/drug effects | 2 | 0.0 |
Proto-Oncogene Proteins c-myc/*metabolism | 2 | 2.0 |
Repressor Proteins/genetics/metabolism | 2 | 2.0 |
Gene Expression Regulation, Neoplastic | 4 | 0.0 |
Genes, myc/*genetics | 2 | 2.0 |
RNA, Messenger/biosynthesis/genetics | 2 | 0.0 |
Transcription Factors/*biosynthesis/genetics | 2 | 2.0 |
Mice, Transgenic | 2 | 0.0 |
